High concentration antibody and protein formulations
US-9849181-B2 · Dec 26, 2017 · US
against protease inhibitors of peptide structure
against protease inhibitors of peptide structure · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07K16/38 |
| Official title | against protease inhibitors of peptide structure |
| Display label | against protease inhibitors of peptide structure |
| Total patents | 237 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is declining.
| Year | Patents |
|---|---|
| 2015 | 11 |
| 2016 | 17 |
| 2017 | 35 |
| 2018 | 32 |
| 2019 | 24 |
| 2020 | 26 |
| 2021 | 19 |
| 2022 | 25 |
| 2023 | 19 |
| 2024 | 15 |
| 2025 | 14 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Antibodies to plasminogen activator inhibitor-1 (PAI-1) and uses thereof
US-9845363-B2 · Dec 19, 2017 · US
Monoclonal antibodies against tissue factor pathway inhibitor (tfpi)
US-2017342162-A1 · Nov 30, 2017 · US
Method and reagent for detecting ovarian clear cell adenocarcinoma
US-2017322218-A1 · Nov 9, 2017 · US
Anti-human PAI-1 antibody
US-9803024-B2 · Oct 31, 2017 · US
Stable antibody containing compositions
US-9795674-B2 · Oct 24, 2017 · US
Methods and Compositions for the Detection and Diagnosis of Renal Disease and Periodontal Disease
US-2017269101-A1 · Sep 21, 2017 · US
Antibodies capable of binding two epitopes on tissue factor pathway inhibitor (1-161)
US-2017260289-A1 · Sep 14, 2017 · US
Dual targeting of tafi and pai-1
US-2017253664-A2 · Sep 7, 2017 · US
Functional Peptide Analogs of PEDF
US-2017253646-A1 · Sep 7, 2017 · US
Pancreatic cancer targets and uses thereof
US-2017219591-A1 · Aug 3, 2017 · US
Method and kit for detecting bacterial infection
US-2017212117-A1 · Jul 27, 2017 · US
Antagonistic peptides
US-2017204140-A1 · Jul 20, 2017 · US
Novel peptides and combination of peptides for use in immunotherapy against various cancers
US-2017189508-A1 · Jul 6, 2017 · US
Novel peptides and combination of peptides for use in immunotherapy against various cancers
US-2017189513-A1 · Jul 6, 2017 · US
Novel peptides and combination of peptides for use in immunotherapy against various cancers
US-2017189512-A1 · Jul 6, 2017 · US
Novel peptides and combination of peptides for use in immunotherapy against various cancers
US-2017189507-A1 · Jul 6, 2017 · US
Novel peptides and combination of peptides for use in immunotherapy against various cancers
US-2017189506-A1 · Jul 6, 2017 · US
Novel peptides and combination of peptides for use in immunotherapy against various cancers
US-2017189504-A1 · Jul 6, 2017 · US
Novel peptides and combination of peptides for use in immunotherapy against various cancers
US-2017189505-A1 · Jul 6, 2017 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07K16/38?
- CPC C07K16/38 is the Cooperative Patent Classification code for “against protease inhibitors of peptide structure.”
- How many patents are filed under CPC C07K16/38 (against protease inhibitors of peptide structure)?
- Our database includes 237 publications tagged with this CPC code.
- Is patent activity under CPC C07K16/38 growing?
- Publication counts under this code: 15 in 2024 vs 14 in 2025 (latest complete years).